Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBP) Shares Issued (2023 - 2025)

Regen BioPharma (RGBP) has disclosed Shares Issued for 6 consecutive years, with $191800.0 as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued changed N/A to $191800.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $543225.0, a N/A change, with the full-year FY2025 number at $58200.0, down 89.68% from a year prior.
  • Shares Issued was $191800.0 for Q4 2025 at Regen BioPharma, up from $28162.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $212297.0 in Q4 2023 to a low of $28162.0 in Q3 2024.
  • A 3-year average of $151104.4 and a median of $187937.0 in 2024 define the central range for Shares Issued.